Stock Track | IQVIA Plummets 10.51% Intraday Amid Elevated Cancellations and CRO Sector Pressures

Stock Track02-13

IQVIA's stock plummeted 10.51% during intraday trading on Thursday, reflecting broad concerns in the contract research organization (CRO) sector.

The decline follows the company's recent report of elevated cancellations earlier this month. The sector is facing multiple headwinds, including a lighter regulatory touch on clinical trials and the Trump administration's push to lower drug prices, which could reduce demand for research and development services.

These factors have contributed to significant declines across CRO stocks in February, with IQVIA's shares having shed approximately 28% for the month amid the challenging environment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171196273?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-13 01:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171196273","market":"us","top_or_hot":-1,"title":"Stock Track | IQVIA Plummets 10.51% Intraday Amid Elevated Cancellations and CRO Sector Pressures","media":"Stock Track","content":"<p>IQVIA's stock plummeted 10.51% during intraday trading on Thursday, reflecting broad concerns in the contract research organization (CRO) sector.</p><p>The decline follows the company's recent report of elevated cancellations earlier this month. The sector is facing multiple headwinds, including a lighter regulatory touch on clinical trials and the Trump administration's push to lower drug prices, which could reduce demand for research and development services.</p><p>These factors have contributed to significant declines across CRO stocks in February, with IQVIA's shares having shed approximately 28% for the month amid the challenging environment.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | IQVIA Plummets 10.51% Intraday Amid Elevated Cancellations and CRO Sector Pressures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | IQVIA Plummets 10.51% Intraday Amid Elevated Cancellations and CRO Sector Pressures\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-13 01:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IQVIA's stock plummeted 10.51% during intraday trading on Thursday, reflecting broad concerns in the contract research organization (CRO) sector.</p><p>The decline follows the company's recent report of elevated cancellations earlier this month. The sector is facing multiple headwinds, including a lighter regulatory touch on clinical trials and the Trump administration's push to lower drug prices, which could reduce demand for research and development services.</p><p>These factors have contributed to significant declines across CRO stocks in February, with IQVIA's shares having shed approximately 28% for the month amid the challenging environment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IQV","symbol_name":"艾昆纬","start_time":0,"source_url":"","article_id":"1171196273","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171196273","pubTimestamp":1770917199,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"IQVIA's stock plummeted 10.51% during intraday trading on Thursday, reflecting broad concerns in the contract research organization (CRO) sector.The decline follows the company's recent report of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IQV":"艾昆纬"},"translate_title":"个股追踪|IQVIA盘中暴跌10.51%，因取消订单增多和CRO行业承压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IQV":1},"content_text":"IQVIA's stock plummeted 10.51% during intraday trading on Thursday, reflecting broad concerns in the contract research organization (CRO) sector.The decline follows the company's recent report of elevated cancellations earlier this month. The sector is facing multiple headwinds, including a lighter regulatory touch on clinical trials and the Trump administration's push to lower drug prices, which could reduce demand for research and development services.These factors have contributed to significant declines across CRO stocks in February, with IQVIA's shares having shed approximately 28% for the month amid the challenging environment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171196273","isCrawlerRequest":true}